Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Society for Translational Oncology (STO) is a non-profit professional organization dedicated to accelerating the discovery and translation of new cancer treatments into standard clinical practice. STO facilitates collaboration among clinical investigators, basic scientists, and the pharmaceutical industry to improve outcomes for cancer patients worldwide. The society is well-known for publishing the peer-reviewed journal The Oncologist and hosting international educational programs and symposia. Through its Global Health Initiative, STO works to bridge the gap in cancer care and research between developed and developing nations. It serves as a critical bridge between laboratory research and clinical application in the field of oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Society for Translational Oncology.